Ingevity (NGVT)
(Delayed Data from NYSE)
$38.44 USD
+1.94 (5.32%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $38.46 +0.02 (0.05%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$38.44 USD
+1.94 (5.32%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $38.46 +0.02 (0.05%) 7:58 PM ET
5-Strong Sell of 5 5
C Value D Growth C Momentum D VGM
Zacks News
Flexible Solutions (FSI) Q2 Earnings & Sales Top Estimates
by Zacks Equity Research
Flexible Solutions' (FSI) Biodegradable Polymers sales rise in Q2 on higher customer orders.
American Vanguard (AVD) Q2 Earnings and Sales Miss Estimates
by Zacks Equity Research
Unfavorable market conditions weigh on American Vanguard's (AVD) top line in the second quarter.
Koppers (KOP) Earnings Surpass Estimates, Sales Lag in Q2
by Zacks Equity Research
Koppers (KOP) sees record sales in its Railroad and Utility Products and Services segment on higher pricing and increased crosstie and utility poles volumes in Q2.
Ingevity's (NGVT) Earnings and Revenues Miss Estimates in Q2
by Zacks Equity Research
Ingevity's (NGVT) top line declines in Q2 due to the Performance Chemicals segment's repositioning, which included limiting exposure to specific markets within the Industrial Specialties product line.
Ingevity (NGVT) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of -3.81% and 5.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Ingevity (NGVT), Ultrapolymers Tie-Up for Capa Bioplastics Sales
by Zacks Equity Research
The addition of a new distribution partner in Europe devoted to Ingevity's (NGVT) Capa biodegradable thermoplastics allows the company to better service its customers in the region.
Ingevity (NGVT) Down 12.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hawkins (HWKN) Earnings Lag Estimates in Q4, Revenues Beat
by Zacks Equity Research
Hawkins (HWKN) sees strong growth in the Water Treatment segment in the fiscal fourth quarter.
American Vanguard (AVD) Q1 Earnings Beat, Sales Miss Estimates
by Zacks Equity Research
American Vanguard's (AVD) U.S. crop business registers strong sales of granular soil insecticides, herbicides and cotton and peanut products in Q1.
Innospec's (IOSP) Q1 Earnings Surpass Estimates, Sales Lag
by Zacks Equity Research
Strong results in the Performance Chemicals segment drove Innospec's (IOSP) earnings in Q1.
Valvoline's (VVV) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
Valvoline's (VVV) fiscal second-quarter earnings and revenues surpass estimates on higher system-wide same-store sales.
Ingevity's (NGVT) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
The decline in sales of Ingevity (NGVT) is predominantly due to the repositioning of the Performance Chemicals unit in Q1.
Linde's (LIN) Q1 Earnings Beat Estimates on Higher Pricing
by Zacks Equity Research
Higher pricing from the Americas segment aids Linde's (LIN) Q1 earnings, offset partially by lower contributions from the Engineering business unit.
Ingevity (NGVT) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Ingevity (NGVT) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Ingevity (NGVT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 40.54% and 6.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Wil Higher Uranium Prices Aid Energy Fuels' (UUUU) Q1 Earnings?
by Zacks Equity Research
Energy Fuels' (UUUU) first-quarter 2024 results are likely to reflect increased uranium sales, as the company is expected to have capitalized on the elevated prices witnessed throughout the quarter.
Olin's (OLN) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
Olin's (OLN) first-quarter earnings and sales surpass the respective estimates as strong Winchester results offset the weakness in its Chemical businesses.
Air Products (APD) Earnings Beat, Revenues Miss Estimates in Q2
by Zacks Equity Research
Air Products' (APD) fiscal second-quarter earnings surpass estimates while sales miss the same due to lower volumes.
Albemarle (ALB) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher lithium volumes and its cost and productivity actions in the first quarter amid headwinds from softer lithium market prices.
Will Lower Production Weigh on Barrick's (GOLD) Q1 Earnings?
by Zacks Equity Research
Lower gold production and higher costs are likely to have affected Barrick's (GOLD) Q1 performance.
WestRock (WRK) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
WestRock's (WRK) Q2 results are likely to reflect lower volumes due to muted customer spending.
Mosaic (MOS) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Mosaic's (MOS) Q1 results are likely to reflect favorable demand for phosphate and potash amid headwinds from weaker fertilizer prices.
DuPont (DD) Gears Up for Q1 Earnings: What's in the Cards?
by Zacks Equity Research
DuPont (DD) is expected to have benefited from its innovation-driven investment and pricing and productivity actions in the first quarter amid demand headwinds.
Analysts Estimate AdvanSix (ASIX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
AdvanSix (ASIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LyondellBasell (LYB) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
LyondellBasell's (LYB) first-quarter results are likely to be affected by weaker demand amid economic uncertainties.